|
May 10
|
Why Iovance Stock Is Down 18% Today
|
|
May 10
|
Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says
|
|
May 10
|
Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ...
|
|
May 10
|
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
|
|
May 9
|
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
|
|
Mar 7
|
1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17?
|
|
Mar 6
|
Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst
|
|
Jan 15
|
Iovance (IOVA) Surges More Than 150% in 3 Months: Here's Why
|
|
Jan 15
|
Zacks.com featured highlights Universal Stainless & Alloy, Lakeland, NGL Energy and Iovance
|
|
Jan 12
|
4 Best Breakout Stocks to Buy for Stellar Returns
|